James Brenton
Cambridge medical oncologist and Interim Deputy Director of the CRUK Cambridge Institute, a leader in ovarian cancer genomics and ctDNA monitoring.
Overview
James Brenton is Interim Deputy Director and a Senior Group Leader at the Cancer Research UK Cambridge Institute, and a consultant medical oncologist at Cambridge University Hospitals. His research focuses on the genomics and evolution of high-grade serous ovarian cancer and on circulating tumour DNA as a tool for treatment monitoring. He leads the ovarian cancer programme within the CRUK Cambridge Centre.
Pages like this
not linked directly; found by shared links- PersonJason Carroll
Shares Cancer Research UK Cambridge Centre / CRUK Cambridge Institute and the tags leadership, clinician-scientist.
- PersonCharlie Gourley
Shares Ovarian cancer and the tags leadership, clinician-scientist, ovarian cancer.
- PersonKunle Odunsi
Shares Ovarian cancer and the tags leadership, clinician-scientist, ovarian cancer.
- PersonThomas Herzog
Shares Ovarian cancer and the tags leadership, clinician-scientist, ovarian cancer.
- PersonJalid Sehouli
Shares Ovarian cancer and the tags leadership, clinician-scientist, ovarian cancer.
- PersonAntonio González-Martín
Shares Ovarian cancer and the tags leadership, clinician-scientist, ovarian cancer.
- PersonRobert S. Mannel
Shares Ovarian cancer and the tags leadership, clinician-scientist.
- PersonAne Gerda Eriksson
Shares Ovarian cancer and the tags leadership, clinician-scientist.